Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance TrialVega, Silvio ; Dowzicky, Michael JAnnals of clinical microbiology and antimicrobials, 2017-07, Vol.16 (1), p.50-50, Article 50 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
|
2 |
Material Type: Artigo
|
Global assessment of antimicrobial susceptibility among Gram-negative organisms collected from pediatric patients between 2004 and 2012: results from the Tigecycline Evaluation and Surveillance TrialKehl, Sue C ; Dowzicky, Michael J Onderdonk, A. B.Journal of clinical microbiology, 2015-04, Vol.53 (4), p.1286-1293 [Periódico revisado por pares]United States: American Society for MicrobiologyTexto completo disponível |
|
3 |
Material Type: Artigo
|
Antimicrobial Susceptibility Among Gram-Negative Isolates Collected From Intensive Care Units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa Between 2004 and 2009 as Part of the Tigecycline Evaluation and Surveillance TrialBertrand, Xavier, PharmD, PhD ; Dowzicky, Michael J., MSClinical therapeutics, 2012, Vol.34 (1), p.124-137 [Periódico revisado por pares]Bridgewater, NJ: EM Inc USATexto completo disponível |
|
4 |
Material Type: Artigo
|
Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance TrialGiammanco, Anna ; Calà, Cinzia ; Fasciana, Teresa ; Dowzicky, Michael J Bradford, Patricia A.mSphere, 2017-01, Vol.2 (1) [Periódico revisado por pares]United States: American Society for MicrobiologyTexto completo disponível |
|
5 |
Material Type: Artigo
|
Antimicrobial Susceptibility among Gram-Positive Organisms Collected from Pediatric Patients Globally between 2004 and 2011: Results from the Tigecycline Evaluation and Surveillance TrialBrandon, Michael ; Dowzicky, Michael JJournal of Clinical Microbiology, 2013-07, Vol.51 (7), p.2371-2378 [Periódico revisado por pares]United States: American Society for MicrobiologyTexto completo disponível |
|
6 |
Material Type: Artigo
|
Changes in MIC Within a Global Collection of Acinetobacter baumannii Collected as Part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009Morfin-Otero, Rayo, MD ; Dowzicky, Michael J., MSClinical therapeutics, 2012, Vol.34 (1), p.101-112 [Periódico revisado por pares]Bridgewater, NJ: EM Inc USATexto completo disponível |
|
7 |
Material Type: Artigo
|
Global in vitro activity of tigecycline and comparator agents: Tigecycline Evaluation and Surveillance Trial 2004-2013Hoban, Daryl J ; Reinert, Ralf Rene ; Bouchillon, Samuel K ; Dowzicky, Michael JAnnals of clinical microbiology and antimicrobials, 2015-05, Vol.14 (1), p.27-27, Article 27 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
|
8 |
Material Type: Artigo
|
Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010Fernández-Canigia, Liliana ; Dowzicky, Michael JAnnals of clinical microbiology and antimicrobials, 2012-10, Vol.11 (1), p.29-29 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
|
9 |
Material Type: Artigo
|
In vitro activity of tigecycline and comparators (2014–2016) among key WHO ‘priority pathogens’ and longitudinal assessment (2004–2016) of antimicrobial resistance: a report from the T.E.S.T. studySeifert, Harald ; Blondeau, Joseph ; Dowzicky, Michael J.International journal of antimicrobial agents, 2018-10, Vol.52 (4), p.474-484 [Periódico revisado por pares]Netherlands: Elsevier B.VTexto completo disponível |
|
10 |
Material Type: Artigo
|
Assessment of the Activity of Tigecycline against Gram-Positive and Gram-Negative Organisms Collected from Italy between 2012 and 2014, as Part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.)Stefani, Stefania ; Dowzicky, Michael JPharmaceuticals (Basel, Switzerland), 2016-11, Vol.9 (4), p.74 [Periódico revisado por pares]Switzerland: MDPI AGTexto completo disponível |